In Vitro Diagnostics Quality Control Market Development | Industry Report 2025

According to research report the global In Vitro Diagnostics Quality Control Market
is projected to reach USD 1,158 million by 2025 from USD 961 million
in 2020, at a CAGR of 3.8% during the forecast period. The market for
IVD quality control is primarily driven by increasing demands for
laboratory accreditation, as well as the rising number of accredited
laboratories and growing adoption of third-party quality controls.
However, the lack of regulations for clinical laboratory accreditation
in several emerging countries will challenge market growth.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582

Based
on product and service, the IVD quality control market is segmented
into quality control products, data management solutions, and quality
assurance services. In 2019, quality control products accounted for the
largest share of the global IVD quality control market. Growth in the
quality control products market can be attributed to the growth in the
number of IVD tests being performed every year along with the increasing
number of accredited laboratories.

Based on manufacturer, the
IVD quality control market is segmented into third-party controls and
original equipment manufacturers (OEMs). In 2019, the third-party
controls segment accounted for the largest share of the global IVD
quality control market. The large share of this segment can be
attributed to the increasing use of third-party quality controls due to
their benefits, such as longer shelf-life and flexibility across
different reagent lots, which helps reduce costs.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198032582

The
market is segmented into five major regions, namely, North America,
Europe, the Asia Pacific (APAC), Latin America, and the Middle East
& Africa. In 2019, the North America accounted for the largest share
of the IVD quality control market. The factors such as recommendations
and approvals for quality control products from the FDA and College of
American Pathologists (CAP) and the presence of well-established
distribution channels as well as leading companies in the US are driving
the IVD quality control market in North America.